Book contents
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Copyright page
- Contents
- Contributors
- Chapter 1 The Patient’s Perspective
- Chapter 2 Epidemiology of Infertility
- Chapter 3 Investigation of Male Infertility
- Chapter 4 Female Fertility
- Chapter 5 Unexplained Infertility
- Chapter 6 Overview of Management of Male Infertility
- Chapter 7 Semen Analysis and Sperm Function Tests
- Chapter 8 Assessment of Fallopian Tube Patency
- Chapter 9 Endometriosis
- Chapter 10 Congenital Uterine Abnormalities
- Chapter 11 Fibroids and Fertility
- Chapter 12 Tubal Factor Infertility and Tubal Surgery
- Chapter 13 Fertility and the Hypogonadal Male
- Chapter 14 Causes and Investigation of Ovarian Infertility
- Chapter 15 Ovulation Induction for Anovulatory Infertility
- Chapter 16 The Role of Regulation in Reproductive Medicine
- Chapter 17 Common Stimulation Regimens in Assisted Reproductive Technology
- Chapter 18 Oocyte Retrieval and Embryo Transfer
- Chapter 19 Gamete Preparation and Embryo Culture
- Chapter 20 Single Embryo Transfer
- Chapter 21 The Risks of Assisted Reproduction
- Chapter 22 Gamete and Embryo Cryopreservation
- Chapter 23 Quality Management in Reproductive Medicine
- Chapter 24 Early Pregnancy
- Chapter 25 Evaluation and Management of Recurrent Miscarriage
- Chapter 26 Sperm Retrieval
- Chapter 27 Preimplantation Genetic Testing
- Chapter 28 Adjuvant Treatment and Alternative Therapies to Improve Fertility
- Chapter 29 Male Fertility Preservation
- Chapter 30 Female Fertility Preservation
- Chapter 31 Donor Recruitment
- Chapter 32 Gamete Donation
- Chapter 33 Training Opportunities in Reproductive Medicine
- Index
- References
Chapter 28 - Adjuvant Treatment and Alternative Therapies to Improve Fertility
Published online by Cambridge University Press: 03 June 2019
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Subfertility, Reproductive Endocrinology and Assisted Reproduction
- Copyright page
- Contents
- Contributors
- Chapter 1 The Patient’s Perspective
- Chapter 2 Epidemiology of Infertility
- Chapter 3 Investigation of Male Infertility
- Chapter 4 Female Fertility
- Chapter 5 Unexplained Infertility
- Chapter 6 Overview of Management of Male Infertility
- Chapter 7 Semen Analysis and Sperm Function Tests
- Chapter 8 Assessment of Fallopian Tube Patency
- Chapter 9 Endometriosis
- Chapter 10 Congenital Uterine Abnormalities
- Chapter 11 Fibroids and Fertility
- Chapter 12 Tubal Factor Infertility and Tubal Surgery
- Chapter 13 Fertility and the Hypogonadal Male
- Chapter 14 Causes and Investigation of Ovarian Infertility
- Chapter 15 Ovulation Induction for Anovulatory Infertility
- Chapter 16 The Role of Regulation in Reproductive Medicine
- Chapter 17 Common Stimulation Regimens in Assisted Reproductive Technology
- Chapter 18 Oocyte Retrieval and Embryo Transfer
- Chapter 19 Gamete Preparation and Embryo Culture
- Chapter 20 Single Embryo Transfer
- Chapter 21 The Risks of Assisted Reproduction
- Chapter 22 Gamete and Embryo Cryopreservation
- Chapter 23 Quality Management in Reproductive Medicine
- Chapter 24 Early Pregnancy
- Chapter 25 Evaluation and Management of Recurrent Miscarriage
- Chapter 26 Sperm Retrieval
- Chapter 27 Preimplantation Genetic Testing
- Chapter 28 Adjuvant Treatment and Alternative Therapies to Improve Fertility
- Chapter 29 Male Fertility Preservation
- Chapter 30 Female Fertility Preservation
- Chapter 31 Donor Recruitment
- Chapter 32 Gamete Donation
- Chapter 33 Training Opportunities in Reproductive Medicine
- Index
- References
Summary
With initial attempts of failed IVF, and also after miscarriages, it is quite common for women to assume and become convinced that there is a problem in the uterus or their body leading to the “rejection” of the embryos. This may be true for some women, but it is difficult to detect and predict which women this applies to. In fact, chromosomal errors in the embryos are probably the main underlying reason behind all reproductive failures, but uterine factors may have a role [1]. A recent analysis of more than 15,000 high grade blastocysts showed 30–90% were aneuploid, increasing significantly with a woman’s age [2]. Sometimes pre-implantation genetic screening (PGS) is useful either prior to or in conjunction with adjuvant treatment to assess the necessity and limit the number of embryo transfer cycles and repeated use of adjuvant treatments.
- Type
- Chapter
- Information
- Publisher: Cambridge University PressPrint publication year: 2019